MACK

Merrimack Pharmaceuticals, Inc.
MACK

Overview Fund Activity
Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

119 hedge funds and large institutions have $78.7M invested in Merrimack Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
+3
Holders Change %
+2.59%
% of All Funds
2.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
31
Reduced
36
Closed
15
Calls
$242K
Puts
$473K
Net Calls
-$231K
Net Calls Change
+$1.22M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$1.07M
2
Morgan Stanley
2
Morgan Stanley
New York
$758K
3
JGC
3
J. Goldman & Co
New York
$331K
4
Deutsche Bank
4
Deutsche Bank
Germany
$1.63M
5
AL
5
Airain Ltd
Guernsey
$292K

Top Sellers

1
State Street
1
State Street
Massachusetts
$2.79M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$8.44M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$21.4M
4
LIM
4
Lagoda Investment Management
New York
$0
5
AWCI
5
Alpine Woods Capital Investors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CLOS
126
Compagnie Lombard Odier SCmA
Switzerland
– -$20K -826 Closed
FPF
127
FNY Partners Fund
New York
– -$10K -441 Closed
SEI Investments
128
SEI Investments
Pennsylvania
– -$7K -280 Closed
WA
129
WFG Advisors
Texas
– -$3K -127 Closed
FANJ
130
Financial Architects (New Jersey)
New Jersey
– -$2K -64 Closed
2 3 4 5
6